PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
80,855,533
Total 13F shares
76,313,271
Share change
+1,667,000
Total reported value
$3,830,944,634
Put/Call ratio
136%
Price per share
$50.20
Number of holders
199
Value change
+$86,495,993
Number of buys
110
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2022

As of 30 Sep 2022, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 199 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,313,271 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., RTW INVESTMENTS, LP, FRANKLIN RESOURCES INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, Camber Capital Management LP, and JANUS HENDERSON GROUP PLC. This page lists 199 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.